Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.51 |
| ▸ | LPL | P06858 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 7/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18815954 | 0.85 | LPL (0.53) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL19679556 | 0.84 | LPL (0.47) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL23624458 | 0.83 | LIPG (0.73) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL13559018 | 0.83 | LIPG (0.73) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL13518679 | 0.83 | LIPG (0.73) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL13172356 | 0.82 | LIPG (0.57) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL13172545 | 0.81 | LIPG (0.56) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL31369065 | 0.81 | LIPG (0.50) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL1534927 | 0.81 | LIPG (0.50) | LIPGLPLMEN1KMT2AMAPT | |
| SCHEMBL22649983 | 0.81 | LIPG (0.55) | LIPGLPLMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11498910-B2 | Compound, organic electroluminescent device and display device | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2022-11-15 | — | — | US | disclosed |
| CN-112358473-B | Heteroanthracene derivative and application thereof and organic electroluminescent device | 武汉尚赛光电科技有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-112358473-A | Heteroanthracene derivative, application thereof and organic electroluminescent device | 武汉尚赛光电科技有限公司 | 2021-02-12 | — | — | CN | disclosed |
| US-10510966-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-12-17 | — | — | US | disclosed |
| US-10377740-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| EP-3351545-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
| US-20180051003-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-22 | — | — | US | disclosed |
| US-20180051003-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-22 | — | — | US | disclosed |
| US-20170352816-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11498910-B2 | Compound, organic electroluminescent device and display device | C1S, OR10J3, L1CAM | LIPG 2909/4885LPL 674/4885MEN1 2048/4885 |
| US-10377740-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | LIPG 2949/4885LPL 2047/4885MEN1 798/4885 |
| US-20180051003-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, NR2E3 | LIPG 2949/4885LPL 2047/4885MEN1 798/4885 |
| US-20170352816-A1 | ORGANIC LIGHT-EMITTING DEVICE | ARL1, CRY2, CRY1 | LIPG 3333/4885LPL 1926/4885MEN1 1368/4885 |
| US-10510966-B2 | Organic light-emitting device | ARL1, CRY2, CRY1 | LIPG 3333/4885LPL 1926/4885MEN1 1368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.